DL 071IT

• Description:

  DL 071IT is a potent non-selective beta-adrenergic receptor blocker. DL 071IT exhibits intrinsic sympathomimetic activity and weak membrane stabilizing activity. DL 071IT reduces exercise heart rate and systolic blood pressure, and even significantly lowers resting heart rate[1].

• UNSPSC:

  12352005

• Hazard Statement:

  H302, H315, H319, H335

• Target:

  Adrenergic Receptor

• Type:

  Reference compound

• Related Pathways:

  GPCR/G Protein; Neuronal Signaling

• Applications:

  Metabolism-protein/nucleotide metabolism

• Field of Research:

  Endocrinology; Cardiovascular Disease

• Assay Protocol:

  https://www.medchemexpress.com/dl-071it.html

• Purity:

  98.81

• Solubility:

  DMSO : 100 mg/mL (ultrasonic)

• Smiles:

  CC(C)(C)NCC(O)COC1=CC=CC(CO2)=C1C2=O.[H]Cl

• Molecular Formula:

  C15H22ClNO4

• Molecular Weight:

  315.79

• Precautions:

  H302, H315, H319, H335

• References & Citations:

  [1]Radice M, et al. Pharmacodynamic studies in man of the beta-adrenoceptor antagonist DL 071 IT. Eur J Clin Pharmacol. 1979 Sep;16 (2) :87-90.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• Isoform:

  β adrenergic receptor

• CAS Number:

  55104-39-7